~~<i id='781AC245FB'><strike id='781AC245FB'><tt id='781AC245FB'><pre id='781AC245FB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：fashion 2025-10-01 02:15:24 - browse：7521

For a decade, leading academic institutes and their associated companies fought a bruising, headline-grabbing fight over who held patent rights to CRISPR-Cas9, the revolutionary genome editing tool.

Editas Medicine, the winner of that battle in the U.S., will now cash in.

Vertex Pharmaceuticals and Editas announced Wednesday that Vertex will pay Editas $50 million, along with a series of annual payments through 2034, in exchange for rights to use CRISPR-Cas9 in Casgevy, the sickle cell therapy approved last week.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： FDA approves Sage Therapeutics’ rapid

entertainment

focus

leisure time

explore

4:01FormerPresidentDonaldTrumpwavesashestepsoffhisplaneatRonaldReaganWashingtonNationalAirport,Aug.3

WSS

CDC recommends RSV monoclonal antibody for infants

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Dramatically reducing cancer deaths requires the PASTEUR Act

2 US Navy sailors arrested for allegedly spying for China

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

hotspot

fashion

entertainment

Activists slam private health insurers over coverage restrictions

Alnylam reports growth in sales of rare disease treatments

Apple is now the first public company to be valued at $3 trillion

Attacks on the drug industry will lead to fewer breakthroughs

Medical leaders decry Supreme Court decision on affirmative action

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

United colonoscopy coverage change 'may cost lives,' doctors say

Study links childhood stress with decline in older age

New air purifier tech could be key to improving indoor air quality

Personalized medicine goes far beyond genetics

entertainment

Verily hires former Apple Health leader as chief scientific officer

How to ethically and practically extend health care to all

ProMED, early warning system on disease outbreaks, in peril

ProMED, early warning system on disease outbreaks, in peril

2 US Navy sailors arrested for allegedly spying for China

How I helped Pfizer think through the ethics of Viagra

focus

leisure time

leisure time

explore